Coronavirus Omicron variant, vaccine, and case numbers in the United States: Dec. 2, 2022 – Medical Economics

How Much Harm Is Too Much for a Vaccine? We Already Have the Criteria  The Epoch Times

New published data point to spike protein interactions with estrogen receptors as a cause for coagulopathy in COVID-19 patients, signaling sex effects and a path to improved vaccines  EurekAlert

Cite this work

Our articles and data visualizations rely on work from many different people and organizations. When citing this entry, please also cite the underlying data sources. This entry can be cited as:

BibTeX citation

All visualizations, data, and code produced by Our World in Data are completely open access under the Creative Commons BY license. You have the permission to use, distribute, and reproduce these in any medium, provided the source and authors are credited.

The data produced by third parties and made available by Our World in Data is subject to the license terms from the original third-party authors. We will always indicate the original source of the data in our documentation, so you should always check the license of any such third-party data before use and redistribution.

All of our charts can be embedded in any site.

Reduce vaccine hesitancy by focusing on options | University of Minnesota  UMN News

Valley fever vaccine in the works thanks to researchers at NAU, University of Washington  Arizona's Family

New Vaccine for Parkinson's Moves Closer to 1st Human Trials | Vaccine Spurs Immune Response in 3 Regions of Alpha-synuclein  Parkinson's News Today

Crabs, T-shirt, mugs and tea cups: UK show lifts the lid on Covid vaccine race  WION

Coronavirus Omicron variant, vaccine, and case numbers in the United States: Dec. 1, 2022  Medical Economics

A dream vaccine could stop COVID spread. But will we have to go to India to get it? | Editorial  NJ.com

An HIV Vaccine Might Be Closer Than We Think In Part Thanks to COVID-19  Global Citizen